Stockreport

Oragenics CEO Murphy Leaves, President Redmond Named Interim Replacement [MarketWatch]

Oragenics Inc.  (OGEN) 
NASDAQ:AMEX Investor Relations: ir.oragenics.com
PDF The development-stage pharmaceutical company focused on nasal delivery of medications in neurology and infectious diseases on Monday said Murphy, who joined the board i [Read more]